ALEXION PHARMACEUTICALS, INC.

(ALXN)
SummaryQuotesChartsNewsRatingsCompany 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société ALEXION PHARMACEUTICALS, INC.
05/05Ultomiris met primary endpoint in CHAMPION-NMOSD Phase III trial in adults with neuromy..
AQ
04/28Ultomiris approved in the US for adults with generalised myasthenia gravis
AQ
04/26BREAKING PMPRB NEWS : Another Win For Patients And The Innovative Pharmaceutical Industry
AQ
04/11PMPRB UPDATE : PMPRB Is Accepting Intervener Leave Applications For SOLIRIS Re-hearing
AQ
03/31SCC Leave Denied In Alexion Pharmaceuticals Inc v Canada (Attorney General)
AQ
03/29PMPRB UPDATE : Supreme Court Refuses To Hear Appeal From Decision Restricting Canada's Pat..
AQ
03/18Chugai Pharmaceutical Co., Ltd. - Notice of the Settlement of Patent Infringement Litig..
AQ
03/17AstraZeneca reaches settlement agreement resolving patent litigation related to Ultomir..
AQ
03/01AstraZeneca and Neurimmune close exclusive global collaboration and licence agreement t..
AQ
02/10AstraZeneca sees $4B in COVID vaccine sales as revenue soars
AQ
02/07PRIORITY NEWS : Referral To EBA Gives PCT Joint Applicants Reasons To Rejoice In 2022
AQ
01/25The 2022 PMPRB Outlook For Pharmaceutical Patentees In Canada
AQ
01/10AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to..
AQ
01/07AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to..
AQ
2021M&A market remains strong despite decline in activity
AQ
2021LIFE SCIENCES : Vavilov And The New Regulatory Environment
AQ
2021ALEXION PHARMACEUTICALS : Canada Seeks Leave To Appeal To The Supreme Court In PMPRB Exces..
AQ
2021OCULAR THERAPEUTIX : Announces appointment of karen-leigh edwards as senior vice president..
AQ
2021ALEXION PHARMACEUTICALS : FCA Remits Pricing Decision On ALEXION'S SOLIRIS To PMPRB
AQ
2021ALEXION PHARMACEUTICALS : Update on CHAMPION-ALS Phase III trial of Ultomiris in amyotroph..
AQ
2021ALEXION PHARMACEUTICALS : Canadian Drug Price Review Board Reined In
AQ
2021"THIS COURT DOES NOT SIGN BLANK CHEQ : Federal Court Of Appeal Reverses Canada's Patented ..
AQ
2021ALEXION PHARMACEUTICALS : Termination of Material Definitive Agreements (Form 8-K)
PU
2021ALEXION PHARMACEUTICALS, INC. : Termination of a Material Definitive Agreement, Completion..
AQ
2021ALEXION PHARMACEUTICALS, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
2021ALEXION PHARMACEUTICALS : Announces Positive Topline Results from Phase 3 Study of ULTOMIR..
BU
2021ALEXION PHARMACEUTICALS : AstraZeneca receives final regulatory clearance for the proposed..
AQ
2021ALEXION PHARMACEUTICALS : AstraZeneca receives clearance from the European Commission for ..
AQ
2021ALEXION PHARMACEUTICALS : EU regulators clear Astrazeneca's £28bn takeover of rival Alexio..
AQ
2021ALEXION PHARMACEUTICALS : Caelum and Alexion Present Additional Phase 2 Data Reinforcing S..
AQ
2021ALEXION PHARMACEUTICALS : Caelum and Alexion Present Additional Phase 2 Data Reinforcing S..
BU
2021ALEXION PHARMACEUTICALS :  Alexion Announces FDA Approval of ULTOMIRIS® (ravulizumab-cwvz)..
BU
2021ALEXION PHARMACEUTICALS : AstraZeneca appoints Aradhana Sarin as new Chief Financial Offic..
AQ
2021ALEXION PHARMACEUTICALS : AstraZeneca and Alexion swap senior staff ahead of $39bn deal cl..
AQ
2021ASTRAZENECA : CMA to probe Covid vaccine maker AstraZeneca's £27.5bn US drug deal
AQ
2021ALEXION PHARMACEUTICALS : Submission of Matters to a Vote of Security Holders, Financial S..
AQ
2021ALEXION PHARMACEUTICALS : Caelum and Alexion Announce Upcoming CAEL-101 Data Presentations..
BU
2021ALEXION PHARMACEUTICALS : Announces Upcoming Data Presentations at the 26th European Hemat..
BU
2021ALEXION PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders, Finan..
AQ
2021ALEXION PHARMACEUTICALS : Shareholders Approve Acquisition by AstraZeneca
BU
2021ALEXION PHARMACEUTICALS : Shareholders Approve Acquisition by AstraZeneca (Form 8-K)
PU
2021ALEXION PHARMACEUTICALS, INC. : Other Events (form 8-K)
AQ
2021ALEXION : Q1 Earnings Snapshot
AQ
2021ALEXION PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND ..
AQ
2021ALEXION PHARMACEUTICALS : Reports First Quarter 2021 Results
BU
2021ALEXION PHARMACEUTICALS : UPDATED Alexion to Report First Quarter 2021 Results on Friday, ..
BU
2021ALEXION PHARMACEUTICALS : to Report First Quarter 2021 Results on Monday, May 3, 2021
BU
2021ALEXION PHARMACEUTICALS : AstraZeneca receives US clearance of proposed acquisition of Ale..
AQ
2021ALEXION PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021ALEXION PHARMACEUTICALS : Announces Upcoming Data Presentations at the 73rd Annual Meeting..
BU
2021ALEXION PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2021ALEXION PHARMACEUTICALS : Amendment to Annual Report (SEC Filing - 10-K/A)
PU
2021ALEXION PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND ..
AQ
2021ALEXION : 4Q Earnings Snapshot
AQ
2021ALEXION PHARMACEUTICALS : Reports Fourth Quarter and Full Year 2020 Results
BU
2021ALEXION PHARMACEUTICALS : to Report Fourth Quarter and Full Year 2020 Results on Thursday,..
BU
2021ALEXION PHARMACEUTICALS : Provides Update on Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz..
BU
2021ALEXION PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Regulation ..
AQ
2021ALEXION PHARMACEUTICALS :  Alexion Highlights Commercial, Clinical and Financial Progress ..
BU
2021ALEXION PHARMACEUTICALS : to Present at the 39th Annual J.P. Morgan Healthcare Conference
BU
2020Alexion, Pluralsight rise; SolarWinds, Virgin Galactic fall
AQ
2020ALEXION PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Other Events, ..
AQ
2020ALEXION PHARMACEUTICALS : AstraZeneca to acquire Alexion, accelerating the Company's strat..
AQ
2020ASTRAZENECA : to acquire Alexion Pharmaceuticals Inc
AQ
2020ASTRAZENECA : buying drug developer Alexion for $39 billion
AQ
2020ALEXION PHARMACEUTICALS : AstraZeneca to Acquire Alexion, Accelerating the Company's Strat..
BU
2020ALEXION PHARMACEUTICALS : Receives Marketing Authorization from European Commission for Ne..
AQ
2020ALEXION PHARMACEUTICALS : Receives Marketing Authorization from European Commission for Ne..
BU
2020ALEXION PHARMACEUTICALS : to Present at Upcoming Virtual Investor Conferences
BU
2020ALEXION PHARMACEUTICALS : Caelum and Alexion Announce Upcoming Data Presentations at the 6..
BU
2020ALEXION PHARMACEUTICALS : Announces Upcoming Data Presentations at the 62nd American Socie..
BU
2020ALEXION PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND ..
AQ
2020ALEXION : 3Q Earnings Snapshot
AQ
2020ALEXION PHARMACEUTICALS : Reports Third Quarter 2020 Results
BU
2020ALEXION PHARMACEUTICALS : to Report Third Quarter 2020 Results on Thursday, October 29, 20..
AQ
1  2  3  4  5  6  7  8  9Next